A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy

Local Institution - 0058, Brussels

Local Institution - 0047, Brussels

Local Institution - 0055, Brussels

Local Institution - 0023, Leuven

Local Institution - 0015, Miskolc

Local Institution - 0048, Liège

Local Institution - 0062, Liège

Local Institution - 0045, Joonladup

Local Institution - 0026, Szeged

Local Institution - 0025, Barcelona

Local Institution - 0060, New York

Local Institution - 0065, Caen

Local Institution - 0017, Madrid

Local Institution - 0053, Atlanta

Local Institution - 0063, Toulouse

Local Institution - 0037, Orlando

Local Institution - 0066, Bron

Local Institution - 0072, Paris

Local Institution - 0009, San Francisco

Local Institution - 0010, Garden Grove

Local Institution - 0028, Los Angeles

Local Institution - 0002, Sacramento

Local Institution - 0011, Hartford

Local Institution - 0044, Orlando

Local Institution - 0059, Indianapolis

Local Institution - 0038, Springfield

Local Institution - 0006, Detroit

Local Institution - 0003, Rochester

Local Institution - 0016, St Louis

Local Institution - 0071, Lebanon

Local Institution - 0075, Fort Worth

Local Institution - 0070, Houston

Local Institution - 0008, Seattle

Local Institution - 0040, Tacoma

Local Institution - 0014, Halifax

Local Institution - 0001, London

Local Institution - 0054, Montreal

Local Institution - 0057, Dresden

Local Institution - 0067, Leipzig

Local Institution - 0007, Warsaw

Local Institution - 0052, Rzeszów

Local Institution - 0061, Lodz

Local Institution - 0031, Warsaw

Local Institution - 0033, Warsaw

Local Institution - 0030, Badalona

Local Institution - 0035, Barcelona